Hello, MD Stein, do you have any thoughts on the PR this AM re: NASH and NALFD? The tone of the PR is positive, but I don't know how to interpret the results, i.e., if they are significantly better than current SOC.
Do you think they are suggestive or good enough to justify a Phase 3 trial or accelerated approval by the FDA?